A lot of effort and money are being put into longevity, particularly by Silicon Valley biotech companies as they try to crack the code of lasting health. A recent report from business news channel CNBC said that the “delaying death” market is expected to grow to £480 billion ($972 billion).
Some geroprotective (anti-ageing) medicines